Unknown NA INTERVENTIONAL 2-arm NCT03331224

Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2) (STING2)

Sponsor: Evangelisches Krankenhaus Düsseldorf

Conditions Acute Upper Gastrointestinal Hemorrhage

Interventions Endoscopic Standard therapy (combining two methods) OTSC

Updated 6 times since 2017 Last updated: Oct 31, 2017 Started: Sep 1, 2017 Primary completion: Sep 1, 2019 Completion: Sep 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Upper Gastrointestinal Hemorrhage and is currently ongoing. Evangelisches Krankenhaus Düsseldorf leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Nov 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Nov 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

Dec 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Evangelisches Krankenhaus Düsseldorf
Kliniken Ludwigsburg-Bietigheim gGmbH
University Hospital Freiburg
University Hospital Goettingen
University Hospital Tuebingen
University Hospital Ulm
University Hospital, Essen
University of Leipzig

Data source: Kliniken Ludwigsburg-Bietigheim gGmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ludwigsburg, Germany